153 related articles for article (PubMed ID: 36222869)
1. MRI-based radiomics for pretreatment prediction of response to concurrent chemoradiotherapy in locally advanced cervical squamous cell cancer.
Zhang X; Zhang Q; Chen Y; Wang S; Zhang J; An J; Xie L; Yu X; Zhao X
Abdom Radiol (NY); 2023 Jan; 48(1):367-376. PubMed ID: 36222869
[TBL] [Abstract][Full Text] [Related]
2. MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy.
Zhang X; Zhao J; Zhang Q; Wang S; Zhang J; An J; Xie L; Yu X; Zhao X
Cancer Imaging; 2022 Jul; 22(1):35. PubMed ID: 35842679
[TBL] [Abstract][Full Text] [Related]
3. The Value of Whole-Tumor Texture Analysis of ADC in Predicting the Early Recurrence of Locally Advanced Cervical Squamous Cell Cancer Treated With Concurrent Chemoradiotherapy.
Zhang X; Zhang Q; Xie L; An J; Wang S; Yu X; Zhao X
Front Oncol; 2022; 12():852308. PubMed ID: 35669419
[TBL] [Abstract][Full Text] [Related]
4. Performance of Pretreatment MRI-Based Radiomics in Recombinant Human Endostatin Plus Concurrent Chemoradiotherapy Response Prediction in Nasopharyngeal Carcinoma: A Retrospective Study.
Huang L; Yang Z; Kang M; Ren H; Jiang M; Tang C; Hu Y; Shen M; Lin H; Long L
Technol Cancer Res Treat; 2023; 22():15330338231160619. PubMed ID: 37094106
[TBL] [Abstract][Full Text] [Related]
5. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
[TBL] [Abstract][Full Text] [Related]
6. IVIM-DWI and MRI-based radiomics in cervical cancer: Prediction of concurrent chemoradiotherapy sensitivity in combination with clinical prognostic factors.
Zhang Y; Zhang K; Jia H; Xia B; Zang C; Liu Y; Qian L; Dong J
Magn Reson Imaging; 2022 Sep; 91():37-44. PubMed ID: 35568271
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric magnetic resonance imaging-derived radiomics for the prediction of disease-free survival in early-stage squamous cervical cancer.
Zhou Y; Gu HL; Zhang XL; Tian ZF; Xu XQ; Tang WW
Eur Radiol; 2022 Apr; 32(4):2540-2551. PubMed ID: 34642807
[TBL] [Abstract][Full Text] [Related]
8. Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model.
Cheng X; Zhang Y; Zhu M; Sun R; Liu L; Li X
BMC Med Imaging; 2023 Oct; 23(1):145. PubMed ID: 37779188
[TBL] [Abstract][Full Text] [Related]
9. MRI radiomics in overall survival prediction of local advanced cervical cancer patients tread by adjuvant chemotherapy following concurrent chemoradiotherapy or concurrent chemoradiotherapy alone.
Wei G; Jiang P; Tang Z; Qu A; Deng X; Guo F; Sun H; Zhang Y; Gu L; Zhang S; Mu W; Wang J; Tian J
Magn Reson Imaging; 2022 Sep; 91():81-90. PubMed ID: 35636572
[TBL] [Abstract][Full Text] [Related]
10. MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy.
Shin J; Seo N; Baek SE; Son NH; Lim JS; Kim NK; Koom WS; Kim S
Radiology; 2022 May; 303(2):351-358. PubMed ID: 35133200
[TBL] [Abstract][Full Text] [Related]
11. A multiple-time-scale comparative study for the added value of magnetic resonance imaging-based radiomics in predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Peng W; Wan L; Wang S; Zou S; Zhao X; Zhang H
Front Oncol; 2023; 13():1234619. PubMed ID: 37664046
[TBL] [Abstract][Full Text] [Related]
12. [A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].
Zhang XY; Zhu HT; Li XT; Li YJ; Li ZW; Wang WH; Wu AW; Sun YS; Zhang L
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):228-234. PubMed ID: 35340172
[No Abstract] [Full Text] [Related]
13. Nomograms Combining Clinical and Imaging Parameters to Predict Recurrence and Disease-free Survival After Concurrent Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer.
Zhang Y; Liu L; Zhang K; Su R; Jia H; Qian L; Dong J
Acad Radiol; 2023 Mar; 30(3):499-508. PubMed ID: 36050264
[TBL] [Abstract][Full Text] [Related]
14. Prediction of outcome using pretreatment
Lucia F; Visvikis D; Desseroit MC; Miranda O; Malhaire JP; Robin P; Pradier O; Hatt M; Schick U
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):768-786. PubMed ID: 29222685
[TBL] [Abstract][Full Text] [Related]
15. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric MRI Radiomics for the Early Prediction of Response to Chemoradiotherapy in Patients With Postoperative Residual Gliomas: An Initial Study.
Zhang Z; He K; Wang Z; Zhang Y; Wu D; Zeng L; Zeng J; Ye Y; Gu T; Xiao X
Front Oncol; 2021; 11():779202. PubMed ID: 34869030
[TBL] [Abstract][Full Text] [Related]
17. Radiomics analysis based on multiparametric magnetic resonance imaging for differentiating early stage of cervical cancer.
Wu F; Zhang R; Li F; Qin X; Xing H; Lv H; Li L; Ai T
Front Med (Lausanne); 2024; 11():1336640. PubMed ID: 38371508
[TBL] [Abstract][Full Text] [Related]
18. Prediction of out-of-field recurrence after chemoradiotherapy for cervical cancer using a combination model of clinical parameters and magnetic resonance imaging radiomics: a multi-institutional study of the Japanese Radiation Oncology Study Group.
Ikushima H; Haga A; Ando K; Kato S; Kaneyasu Y; Uno T; Okonogi N; Yoshida K; Ariga T; Isohashi F; Harima Y; Kanemoto A; Ii N; Wakatsuki M; Ohno T
J Radiat Res; 2022 Jan; 63(1):98-106. PubMed ID: 34865079
[TBL] [Abstract][Full Text] [Related]
19. Selecting Candidates for Organ-Preserving Strategies After Neoadjuvant Chemoradiotherapy for Rectal Cancer: Development and Validation of a Model Integrating MRI Radiomics and Pathomics.
Wan L; Sun Z; Peng W; Wang S; Li J; Zhao Q; Wang S; Ouyang H; Zhao X; Zou S; Zhang H
J Magn Reson Imaging; 2022 Oct; 56(4):1130-1142. PubMed ID: 35142001
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of delta radiomics in xerostomia after chemoradiotherapy in patients with stage III-IV nasopharyngeal carcinoma.
Wang M; Xi Y; Wang L; Chen H; Jiang F; Ding Z
Radiat Oncol; 2024 Feb; 19(1):26. PubMed ID: 38418994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
